Drawing for VIRTUALMD

USPTO serial 99466067

VIRTUALMD

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
BODRI, KRISTIN MARIE
Law office
TMEG LAW OFFICE 105

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VIRTUALMD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John D Gugliotta

John D Gugliotta Gugliotta & Gugliotta LPAP.O. Box 506Richfield, OH 44286United States

Goods and services

ClassDescriptionStatusFirst use
042Platform as a service (PAAS) featuring computer software platforms for providing virtual and remote care to patients through video or telephone calls and providing users the ability to utilize ePrescription, Lab orders, document management, electronic claim processing and secure messagingACTIVEJan 1, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 14, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 17, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 17, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Mar 17, 2026CNSLSUSPENSION LETTER WRITTEN—
Mar 12, 2026DOCKASSIGNED TO EXAMINER—
Feb 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 30, 2025TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Oct 30, 2025PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 28, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 28, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance